Isoproterenol inhibits resistin gene expression through a GS-protein-coupled pathway in 3T3-L1 adipocytes

被引:74
作者
Fasshauer, M
Klein, J
Neumann, S
Eszlinger, M
Paschke, R
机构
[1] Univ Leipzig, Dept Internal Med 3, D-04103 Leipzig, Germany
[2] Med Univ Lubeck, Dept Internal Med 1, D-23538 Lubeck, Germany
关键词
resistin; beta-adrenergic receptor; insulin resistance; obesity; 3T3-L1; adipocyte;
D O I
10.1016/S0014-5793(01)02588-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Resistin was recently identified as a hormone secreted by adipocytes which leads to insulin resistance in vivo and in vitro and might therefore be an important link between obesity and diabetes. To clarify the regulation of resistin gene expression, 3T3-L1 adipocytes were treated with various agents known to modulate insulin sensitivity, and resistin mRNA was measured by quantitative real-time reverse transcription-polymerase chain reaction. Interestingly, isoproterenol treatment reduced the level of resistin mRNA to 20% of non-treated control cells. This effect was dose-dependent nifh significant inhibition occurring at concentrations as low as 10 nM isoproterenol, Moreover, pretreatment of adipocytes with the P-adrenergic antagonist propranolol almost completely reversed the inhibitory effect of isoproterenol, whereas addition of the alpha -adrenergic antagonist phentolamine did not have any effect, Furthermore, the effect of isoproterenol could be mimicked by activation of Gs-proteins and adenglyl cyclase. Thus, both cholera toxin and forskolin decreased resistin mRNA expression in a dose-dependent fashion by up to 90% of control levels. Taken together, these results suggest that resistin gene expression is regulated by a protein kinase A-dependent pathway in 3T3-L1 adipocytes, (C) 2001 Federation of European Biochemical Societies, Published by Elsevier Science B,V, AU rights reserved.
引用
收藏
页码:60 / 63
页数:4
相关论文
共 20 条
[1]  
Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513
[2]   Improvement of insulin sensitivity after adrenalectomy in patients with pheochromocytoma [J].
Blüher, M ;
Windgassen, M ;
Paschke, R .
DIABETES CARE, 2000, 23 (10) :1591-1592
[3]   Plasma levels of tumor necrosis factor-α, angiotensin II, growth hormone, and IGF-1 are not elevated in insulin-resistant obese individuals with impaired glucose tolerance [J].
Blüher, M ;
Kratzsch, J ;
Paschke, R .
DIABETES CARE, 2001, 24 (02) :328-334
[4]   The β-adrenergic receptors and the control of adipose tissue metabolism and thermogenesis [J].
Collins, S ;
Surwit, RS .
RECENT PROGRESS IN HORMONE RESEARCH, VOL 56, 2001, 56 :309-328
[5]   Essential role of insulin receptor substrate-2 in insulin stimulation of Glut4 translocation and glucose uptake in brown adipocytes [J].
Fasshauer, M ;
Klein, J ;
Ueki, K ;
Kriauciunas, KM ;
Benito, M ;
White, MF ;
Kahn, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25494-25501
[6]   Essential role of insulin receptor substrate 1 in differentiation of brown adipocytes [J].
Fasshauer, M ;
Klein, J ;
Kriauciunas, KM ;
Ueki, K ;
Benito, M ;
Kahn, CR .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (01) :319-329
[7]   The effect of in vivo thyroxine treatment on insulin receptors, glucose transport and GLUT4 in rat adipocytes [J].
Fickova, M ;
Zorad, S ;
Macho, L .
HORMONE AND METABOLIC RESEARCH, 1997, 29 (01) :16-19
[8]   Antihypertensive therapy and insulin sensitivity:: Do we have to redefine the role of β-blocking agents? [J].
Jacob, S ;
Rett, K ;
Henriksen, EJ .
AMERICAN JOURNAL OF HYPERTENSION, 1998, 11 (10) :1258-1265
[9]   Obesity and insulin resistance [J].
Kahn, BB ;
Flier, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 106 (04) :473-481
[10]   Differential regulation of the dopamine D2 and D3 receptors by G protein-coupled receptor kinases and β-arrestins [J].
Kim, KM ;
Valenzano, KJ ;
Robinson, SR ;
Yao, WD ;
Barak, LS ;
Caron, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :37409-37414